S. 1250Senate116th Congress (2019-2021)In Committee

American Cures Act

Introduced April 30, 2019

AI-Generated Summary

Updated April 14, 2026 at 4:29 AM UTC

The American Cures Act directs the federal government to increase and protect funding for biomedical research. It adds a new “biomedical research” category to the budget‑control law and sets maximum additional budget authority for the NIH, CDC, the Department of Defense health program, and the Veterans Affairs medical and prosthetics research program for fiscal years 2020‑2024. The bill also guarantees that funding for these programs cannot fall below 2019 levels and shields the new appropriations from sequestration.

Key Provisions

  • Creates a new “biomedical research” subparagraph in the budget cap law, specifying maximum additional new budget authority for NIH (up to $15.741 billion in FY2024), CDC (up to $2.938 billion in FY2024), DoD health program (up to $963.306 million in FY2024), and VA medical‑prosthetics research (up to $71.49 million in FY2024).
  • Authorizes the appropriated amounts listed for each agency for FY2020‑2024 and allows continued funding at necessary levels in later years.
  • Requires that annual funding for these programs never drop below the amounts appropriated in FY2019.
  • Exempts the appropriations under this act from any sequestration orders issued after the law’s enactment.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on the Budget. (text: CR S2521-2522)

April 30, 2019

View full timeline
SenateIntro Referral

Introduced in Senate

April 30, 2019

SenateIntro Referral

Read twice and referred to the Committee on the Budget. (text: CR S2521-2522)

April 30, 2019

Floor Debate

4 members

What members said about S. 1250 on the floor

4 Democrats
Jack Reed
Sen. Jack ReedD-RI · Apr 30, 2019

Mr. President, the PCAOB Enforcement Transparency Act, which I reintroduce today with Senator Grassley, will permit the Public Company Accounting Oversight Board (PCAOB) to make public the…

Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Apr 30, 2019

Mr. President, I rise in support of the ``Preventing Online Sales of E-Cigarettes to Children Act,'' which would help address the concerning rise of electronic cigarette use among America's youth.…

Tim Kaine
Sen. Tim KaineD-VA · Apr 30, 2019

Mr. President, I rise today to re-introduce the Fair and Equal Housing Act of 2019, legislation to ensure equal housing opportunities for all Americans. This bipartisan bill would protect Americans…

Richard J. Durbin
Sen. Richard J. DurbinD-IL · Apr 30, 2019

Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.

Richard J. Durbin
Sen. Richard J. DurbinD-IL · Apr 30, 2019

Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued April 30, 2019

II

116th CONGRESS

1st Session

S. 1250

IN THE SENATE OF THE UNITED STATES

April 30, 2019

Mr. Durbin (for himself, Mr. Brown, Mr. Van Hollen, Mr. Cardin, Mr. Casey, Mr. Markey, Ms. Baldwin, Mr. Blumenthal, and Ms. Klobuchar) introduced the following bill; which was read twice and referred to the Committee on the Budget

A BILL

To prioritize funding for an expanded and sustained national investment in biomedical research.

1.

Short title

This Act may be cited as the American Cures Act.

2.

Cap adjustment

(a)

In general

Section 251(b)(2) of the Balanced Budget and Emergency Deficit Control Act of 1985 (2 U.S.C. 901(b)(2)) is amended—

(1)

by redesignating subparagraphs (D), (E), and (F) as subparagraphs (E), (F), and (G), respectively; and

(2)

by inserting after subparagraph (C), the following:

(D)

Biomedical research

(i)

National Institutes of Health

If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the National Institutes of Health at the Department of Health and Human Services, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

(I)

for fiscal year 2020, $2,737,000,000 in additional new budget authority;

(II)

for fiscal year 2021, $5,666,000,000 in additional new budget authority;

(III)

for fiscal year 2022, $8,800,000,000 in additional new budget authority;

(IV)

for fiscal year 2023, $12,153,000,000 in additional new budget authority; and

(V)

for fiscal year 2024, $15,741,000,000 in additional new budget authority.

(ii)

Centers for Disease Control and Prevention

If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the Centers for Disease Control and Prevention at the Department of Health and Human Services, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

(I)

for fiscal year 2020, $511,000,000 in additional new budget authority;

(II)

for fiscal year 2021, $1,057,000,000 in additional new budget authority;

(III)

for fiscal year 2022, $1,642,000,000 in additional new budget authority;

(IV)

for fiscal year 2023, $2,268,000,000 in additional new budget authority; and

(V)

for fiscal year 2024, $2,938,000,000 in additional new budget authority.

(iii)

Department of Defense health program

If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the Department of Defense health program, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

(I)

for fiscal year 2020, $167,510,000 in additional new budget authority;

(II)

for fiscal year 2021, $346,745,700 in additional new budget authority;

(III)

for fiscal year 2022, $538,527,899 in additional new budget authority;

(IV)

for fiscal year 2023, $743,734,852 in additional new budget authority; and

(V)

for fiscal year 2024, $963,306,292 in additional new budget authority.

(iv)

Medical and prosthetics research program of the Department of Veterans Affairs

If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the medical and prosthetics research program of the Department of Veterans Affairs, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

(I)

for fiscal year 2020, $54,530,000 in additional new budget authority;

(II)

for fiscal year 2021, $58,350,000 in additional new budget authority;

(III)

for fiscal year 2022, $62,440,000 in additional new budget authority;

(IV)

for fiscal year 2023, $66,810,000 in additional new budget authority; and

(V)

for fiscal year 2024, $71,490,000 in additional new budget authority.

(v)

Definitions

As used in this subparagraph:

(I)

Additional new budget authority

The term additional new budget authority means—

(aa)

with respect to the National Institutes of Health, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the National Institutes of Health;

(bb)

with respect to the Centers for Disease Control and Prevention, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the Centers for Disease Control and Prevention;

(cc)

with respect to the Department of Defense health program, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the Department of Defense health program; and

(dd)

with respect to the medical and prosthetics research program of the Department of Veterans Affairs, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the medical and prosthetics research program of the Department of Veterans Affairs.

(II)

Centers for Disease Control and Prevention

The term Centers for Disease Control and Prevention means the appropriations accounts that support the various institutes, offices, and centers that make up the Centers for Disease Control and Prevention.

(III)

Department of Defense health program

The term Department of Defense health program means the appropriations accounts that support the various institutes, offices, and centers that make up the Department of Defense health program.

(IV)

Medical and prosthetics research program of the Department of Veterans Affairs

The term medical and prosthetics research program of the Department of Veterans Affairs means the appropriations accounts that support the various institutes, offices, and centers that make up the medical and prosthetics research program of the Department of Veterans Affairs.

(V)

National Institutes of Health

The term National Institutes of Health means the appropriations accounts that support the various institutes, offices, and centers that make up the National Institutes of Health.

.

(b)

Funding

There are hereby authorized to be appropriated—

(1)

for the National Institutes of Health, the amounts provided for under clause (i) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year;

(2)

for the Secretary of Health and Human Services, acting through the Centers for Disease Control and Prevention, the amounts provided for under clause (ii) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year;

(3)

for the Department of Defense health program, the amounts provided for under clause (iii) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year; and

(4)

for the medical and prosthetics research program of the Department of Veterans Affairs, the amounts provided for under clause (iv) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year.

(c)

Minimum Continued Funding Requirement

Amounts appropriated for each of the programs and agencies described in section 251(b)(2)(D) of the Balanced Budget and Emergency Deficit Control Act of 1985 (as added by subsection (a)) for each of fiscal years 2020 through 2024, and each subsequent fiscal year, shall not be less than the amounts appropriated for such programs and agencies for fiscal year 2019.

(d)

Exemption of certain appropriations from sequestration

(1)

In general

Section 255(g)(1)(A) of the Balanced Budget and Emergency Deficit Control Act (2 U.S.C. 905(g)(1)(A)) is amended by inserting after Advances to the Unemployment Trust Fund and Other Funds (16–0327–0–1–600). the following:

Appropriations under the American Cures Act.

.

(2)

Applicability

The amendment made by this section shall apply to any sequestration order issued under the Balanced Budget and Emergency Deficit Control Act of 1985 (2 U.S.C. 900 et seq.) on or after the date of enactment of this Act.